In 1992, silicone breast implants were taken off the market by the FDA due to safety concerns about the effect of silicone implant leaks on the body’s immune system. However, by 2006, years of extensive clinical testing had uncovered absolutely no links between silicone breast implants and any kind of immune system deficiencies. The FDA re-approved silicone breast implants for use in women 22+ years old, and ever since, they have been the preferred choice among many patients and plastic surgeons because of their realistic look and feel.
No medical device has been studied more thoroughly than silicone breast implants. Hundreds of intensive clinical and laboratory trials were performed while the implants were off the market, leading the Academy of Medicine to conclude that they were safe and certainly not leading to any type of immune disease. The FDA agreed with the Academy’s conclusion in 2006, and continues to closely monitor silicone gel for the benefit of patients.
Today’s silicone breast implants are safer than ever. The implants contain a cohesive gel that is designed to stay inside of the implant if a rupture occurs. However, because silicone breast implants are so effective at staying in place, it can be difficult to tell when a rupture has occurred, which is why it’s important for women with silicone implants to have regular MRIs.
If you have further questions about silicone breast implants, please contact Park Plaza Plastic Surgery today to schedule your consultation with New York City board-certified plastic surgeon Dr. George Lefkovits. You can also reach us by phone at (212) 750-9494.